
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7239636
[patent_doc_number] => 20050080252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Process for preparing antiviral nucleoside derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/939819
[patent_app_country] => US
[patent_app_date] => 2004-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7966
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10939819
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/939819 | Process for preparing antiviral nucleoside derivatives | Sep 12, 2004 | Abandoned |
Array
(
[id] => 6990436
[patent_doc_number] => 20050089473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Potassium channel mediated delivery of agents through the blood-brain barrier'
[patent_app_type] => utility
[patent_app_number] => 10/938674
[patent_app_country] => US
[patent_app_date] => 2004-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 61972
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089473.pdf
[firstpage_image] =>[orig_patent_app_number] => 10938674
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/938674 | Potassium channel mediated delivery of agents through the blood-brain barrier | Sep 9, 2004 | Abandoned |
Array
(
[id] => 7127971
[patent_doc_number] => 20050059715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Combinations comprising alpha-2-delta ligands'
[patent_app_type] => utility
[patent_app_number] => 10/935824
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17694
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10935824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/935824 | Combinations comprising alpha-2-delta ligands | Sep 7, 2004 | Abandoned |
Array
(
[id] => 7011460
[patent_doc_number] => 20050065176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Combinations'
[patent_app_type] => utility
[patent_app_number] => 10/936416
[patent_app_country] => US
[patent_app_date] => 2004-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22532
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20050065176.pdf
[firstpage_image] =>[orig_patent_app_number] => 10936416
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/936416 | Combinations | Sep 7, 2004 | Abandoned |
Array
(
[id] => 5074904
[patent_doc_number] => 20070014879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Composition comprising notoginseng radix extract for preventing and treating of arthritis as an effective ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/568257
[patent_app_country] => US
[patent_app_date] => 2004-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5982
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20070014879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568257
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568257 | Composition comprising notoginseng radix extract for preventing and treating of arthritis as an effective ingredient | Sep 5, 2004 | Abandoned |
Array
(
[id] => 4873689
[patent_doc_number] => 20080200423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Novel Tricyclic Nucleosides or Nucleotides as Therapeutic Agents'
[patent_app_type] => utility
[patent_app_number] => 10/568917
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30044
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200423.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568917
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568917 | Tricyclic nucleosides or nucleotides as therapeutic agents | Aug 26, 2004 | Issued |
Array
(
[id] => 303734
[patent_doc_number] => 07534873
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-19
[patent_title] => 'Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil'
[patent_app_type] => utility
[patent_app_number] => 10/926528
[patent_app_country] => US
[patent_app_date] => 2004-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6812
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534873.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926528 | Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil | Aug 25, 2004 | Issued |
Array
(
[id] => 6991516
[patent_doc_number] => 20050090553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Compositions and method for treatment of chronic inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 10/924945
[patent_app_country] => US
[patent_app_date] => 2004-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30382
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090553.pdf
[firstpage_image] =>[orig_patent_app_number] => 10924945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/924945 | Compositions and method for treatment of chronic inflammatory diseases | Aug 23, 2004 | Abandoned |
Array
(
[id] => 5609314
[patent_doc_number] => 20060270830
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Polysialic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/568111
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4902
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568111 | Polysialic acid derivatives | Aug 11, 2004 | Issued |
Array
(
[id] => 5070495
[patent_doc_number] => 20070191597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Sialic acid derivatives for protein derivatisation and conjugation'
[patent_app_type] => utility
[patent_app_number] => 10/568043
[patent_app_country] => US
[patent_app_date] => 2004-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 12183
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568043 | Sialic acid derivatives for protein derivatisation and conjugation | Aug 11, 2004 | Issued |
Array
(
[id] => 7252595
[patent_doc_number] => 20040259245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Complete nutrient medium for use as a cosmetic and cosmetic use thereof'
[patent_app_type] => new
[patent_app_number] => 10/892376
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2711
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259245.pdf
[firstpage_image] =>[orig_patent_app_number] => 10892376
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/892376 | Complete nutrient medium for use as a cosmetic and cosmetic use thereof | Aug 10, 2004 | Abandoned |
Array
(
[id] => 6972303
[patent_doc_number] => 20050038013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Treatment of sleep disorders with cholinesterase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/915821
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6780
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10915821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/915821 | Treatment of sleep disorders with cholinesterase inhibitors | Aug 10, 2004 | Issued |
Array
(
[id] => 7206463
[patent_doc_number] => 20050043274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Pharmaceutical compositions and methods for lowering blood pressure and pulse rate'
[patent_app_type] => utility
[patent_app_number] => 10/909344
[patent_app_country] => US
[patent_app_date] => 2004-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4160
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043274.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909344 | Pharmaceutical compositions and methods for lowering blood pressure and pulse rate | Aug 2, 2004 | Abandoned |
Array
(
[id] => 7033596
[patent_doc_number] => 20050032105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Compositions and methods for using a solid support to purify DNA'
[patent_app_type] => utility
[patent_app_number] => 10/909724
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12204
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032105.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909724
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909724 | Compositions and methods for using a solid support to purify DNA | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7256138
[patent_doc_number] => 20040259818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Glucoronide adduct as gaba ligand'
[patent_app_type] => new
[patent_app_number] => 10/477025
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3766
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10477025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/477025 | Glucoronide adduct as gaba ligand | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7033080
[patent_doc_number] => 20050031589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Method of treating hepatitis C infection'
[patent_app_type] => utility
[patent_app_number] => 10/899726
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2267
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031589.pdf
[firstpage_image] =>[orig_patent_app_number] => 10899726
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/899726 | Method of treating hepatitis C infection | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7127890
[patent_doc_number] => 20050059634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Per-6-substituted-per-6-deoxy-cyclodextrins, and use of the same to inhibit soluble beta-amyloid-peptide derived oligomers and to treat alzheimer\'s and related diseases'
[patent_app_type] => utility
[patent_app_number] => 10/899468
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7473
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059634.pdf
[firstpage_image] =>[orig_patent_app_number] => 10899468
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/899468 | Per-6-substituted-per-6-deoxy-cyclodextrins, and use of the same to inhibit soluble beta-amyloid-peptide derived oligomers and to treat alzheimer's and related diseases | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7083863
[patent_doc_number] => 20050049243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Pharmaceutical composition comprising an AChE inhibitor and a mGluR2 antagonist'
[patent_app_type] => utility
[patent_app_number] => 10/896494
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21687
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20050049243.pdf
[firstpage_image] =>[orig_patent_app_number] => 10896494
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/896494 | Pharmaceutical composition comprising an AChE inhibitor and a mGluR2 antagonist | Jul 21, 2004 | Issued |
Array
(
[id] => 7436434
[patent_doc_number] => 20040266876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Method for preventing and treating visceral pain and gastrointestinal disorders'
[patent_app_type] => new
[patent_app_number] => 10/894447
[patent_app_country] => US
[patent_app_date] => 2004-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16647
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266876.pdf
[firstpage_image] =>[orig_patent_app_number] => 10894447
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/894447 | Method for preventing and treating visceral pain and gastrointestinal disorders | Jul 18, 2004 | Abandoned |
Array
(
[id] => 5618973
[patent_doc_number] => 20060188506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Therapy-enhancing glucan'
[patent_app_type] => utility
[patent_app_number] => 10/565484
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 9176
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188506.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565484
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565484 | Therapy-enhancing glucan | Jul 15, 2004 | Issued |